Mirion Technologies, Inc.

Mirion Technologies provides radiation detection, measurement, analysis, and monitoring products and services across North America, Europe, and Asia Pacific. The company operates through two distinct business segments addressing different end-market applications. The Medical segment supplies radiation oncology quality assurance and dosimetry solutions, patient safety systems for diagnostic imaging and radiation therapy centers, radiation therapy calibration and verification tools, and radionuclide therapy products including medical imaging furniture and rehabilitation equipment. The Nuclear & Safety segment focuses on radiation safety and measurement solutions, including personal radiation detection equipment, reactor instrumentation and control detectors, imaging systems, contamination and clearance monitors, laboratory spectroscopy systems, and health physics instrumentation.

The company serves a diverse customer base spanning hospitals, clinics, dental and veterinary facilities, radiation treatment centers, equipment manufacturers, laboratories, military and government agencies, industrial companies, and nuclear power plants. Mirion Technologies operates as a public company listed on the NYSE with approximately 3,281 full-time employees and headquarters in Atlanta, Georgia. The company was originally incorporated in 2005 and operates under its current name following a 2006 rebranding from Global Monitoring Systems, Inc.